168 related articles for article (PubMed ID: 29806214)
1. Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection.
Tomovic K; Lazarevic J; Kocic G; Deljanin-Ilic M; Anderluh M; Smelcerovic A
Med Res Rev; 2019 Jan; 39(1):404-422. PubMed ID: 29806214
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase-4 inhibition and renoprotection: the role of antifibrotic effects.
Takagaki Y; Koya D; Kanasaki K
Curr Opin Nephrol Hypertens; 2017 Jan; 26(1):56-66. PubMed ID: 27820706
[TBL] [Abstract][Full Text] [Related]
3. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S
Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease.
Akoumianakis I; Antoniades C
Vascul Pharmacol; 2017 Sep; 96-98():1-4. PubMed ID: 28697993
[TBL] [Abstract][Full Text] [Related]
6. Impact of dipeptidyl-peptidase 4 inhibitors on cardiovascular diseases.
Xie W; Song X; Liu Z
Vascul Pharmacol; 2018 Oct; 109():17-26. PubMed ID: 29879463
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl peptidase-4 inhibitors: multitarget drugs, not only antidiabetes drugs.
Zhao Y; Yang L; Zhou Z
J Diabetes; 2014 Jan; 6(1):21-9. PubMed ID: 23683065
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
9. Critical role of renal dipeptidyl peptidase-4 in ameliorating kidney injury induced by saxagliptin in Dahl salt-sensitive hypertensive rats.
Sakai M; Uchii M; Myojo K; Kitayama T; Kunori S
Eur J Pharmacol; 2015 Aug; 761():109-15. PubMed ID: 25936515
[TBL] [Abstract][Full Text] [Related]
10. Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH
Salaga M; Binienda A; Draczkowski P; Kosson P; Kordek R; Jozwiak K; Fichna J
Peptides; 2018 Oct; 108():34-45. PubMed ID: 30179653
[TBL] [Abstract][Full Text] [Related]
11. Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease.
Panchapakesan U; Mather A; Pollock C
Clin Sci (Lond); 2013 Jan; 124(1):17-26. PubMed ID: 22963445
[TBL] [Abstract][Full Text] [Related]
12. More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling.
Gupta S; Sen U
Pharmacol Res; 2019 Sep; 147():104391. PubMed ID: 31401210
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of DPP-4 inhibition: beyond GLP-1.
Fadini GP; Avogaro A
Vascul Pharmacol; 2011; 55(1-3):10-6. PubMed ID: 21664294
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.
Koska J; Sands M; Burciu C; Reaven P
Diab Vasc Dis Res; 2015 May; 12(3):154-63. PubMed ID: 25852133
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.
Penno G; Garofolo M; Del Prato S
Nutr Metab Cardiovasc Dis; 2016 May; 26(5):361-73. PubMed ID: 27105869
[TBL] [Abstract][Full Text] [Related]
16. DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs.
Zhang J; Chen Q; Zhong J; Liu C; Zheng B; Gong Q
Front Immunol; 2019; 10():1050. PubMed ID: 31134095
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase-4 inhibitors in progressive kidney disease.
Makino Y; Fujita Y; Haneda M
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):67-73. PubMed ID: 25415611
[TBL] [Abstract][Full Text] [Related]
18. Role of Dipeptidyl Peptidase-4 in Atherosclerotic Cardiovascular Disease in Humans and Animals with Chronic Stress.
Piao L; Li Y; Narisawa M; Shen X; Cheng XW
Int Heart J; 2021 May; 62(3):470-478. PubMed ID: 33994495
[TBL] [Abstract][Full Text] [Related]
19. The emerging role of dipeptidyl peptidase-4 inhibitors in cardiovascular protection: current position and perspectives.
Wang XM; Yang YJ; Wu YJ
Cardiovasc Drugs Ther; 2013 Aug; 27(4):297-307. PubMed ID: 23645229
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
